• Home
  • the Face of Dementia?
  • myAVOS
  • Team
  • Scientific Advisors
  • Sustainable Healthcare
  • Media Release
  • Blog
  • About OptiChroniX
  • Science
  • Contact
  • EULA
  • More
    • Home
    • the Face of Dementia?
    • myAVOS
    • Team
    • Scientific Advisors
    • Sustainable Healthcare
    • Media Release
    • Blog
    • About OptiChroniX
    • Science
    • Contact
    • EULA
  • Home
  • the Face of Dementia?
  • myAVOS
  • Team
  • Scientific Advisors
  • Sustainable Healthcare
  • Media Release
  • Blog
  • About OptiChroniX
  • Science
  • Contact
  • EULA

Team

Rene Gilvert

Swayambhu Raparti

Swayambhu Raparti

Founder and CEO


Rene is a life science professional with more than 25 years of pharmaceutical commercial and development experience in GSK, Organon, Novartis and Takeda

 
Former Vice President of Global Franchises in Neuroscience and CVM at Takeda


>10  years of leadership experience in developing Digital Solutions and Digital Therapeutics,

Founder and CEO


Rene is a life science professional with more than 25 years of pharmaceutical commercial and development experience in GSK, Organon, Novartis and Takeda

 
Former Vice President of Global Franchises in Neuroscience and CVM at Takeda


>10  years of leadership experience in developing Digital Solutions and Digital Therapeutics, at both Novartis and Takeda, where he developed Digital Therapeutic concepts in NeuroPsychiatric disorders.

Rene holds a B.Sc in Information Management from the University of Applied Sciences Larenstein


Executive training certification in Finance from the Harvard Business School


Swayambhu Raparti

Swayambhu Raparti

Swayambhu Raparti

President OptiChroniX Inc and CTO

Mr. Raparti has over two decades of software development experience, including over 14 years of building healthcare technology platforms to democratize data. 


He has built platforms that leverage a variety of techniques, including native cloud, edge computing, IoT and AI/ML, to collect and organize inform

President OptiChroniX Inc and CTO

Mr. Raparti has over two decades of software development experience, including over 14 years of building healthcare technology platforms to democratize data. 


He has built platforms that leverage a variety of techniques, including native cloud, edge computing, IoT and AI/ML, to collect and organize information from EHRs/EMRs, LIMS/LIS, patient portals, and lab work flows.

Mr. Raparti will manage the Software Development, Enterprise IT and Data Science teams to design, develop and deliver high traffic, large scale technology platforms to enable integrations, interoperability and data insights.


Raparti has held several software technical lead and senior engineering leadership roles at Sema4, Equinix, eProcrates, Cryptography, and Genentech.


Raparti has a Master of Science in Computer Software from Carnegie Mellon University.



Roger Bullock, MD

Swayambhu Raparti

Anna Grabowski, MSc

Clinical Development

Roger qualified in medicine 1981 and has worked in surgery, medicine and A&E until training in psychiatry 1987-1990.
Specialized in geriatric psychiatry.
NHS consultant 1993-2013
Set up Kingshill Research Centre in 1994 developing it in to a national and international facility. 


UK coordinating investigator on many o

Clinical Development

Roger qualified in medicine 1981 and has worked in surgery, medicine and A&E until training in psychiatry 1987-1990.
Specialized in geriatric psychiatry.
NHS consultant 1993-2013
Set up Kingshill Research Centre in 1994 developing it in to a national and international facility. 


UK coordinating investigator on many occasions. Published over 100 peer reviewed papers, several books and chapters
8 years as clinical tutor and 4 years as Academic Secretary of the Royal College of Psychiatrists Faculty of Old age Psychiatry. Invited speaker at many national and international conferences

Worked 11 years in senior NHS management - last six as Clinical director of Older Peoples services.

Successfully responsible for a 55m budget and clinical governance of 800 staff

Anna Grabowski, MSc

Albrecht Tribukait, PhD, MBA

Anna Grabowski, MSc

Finance and Operations


Anna has significant experience in controlling, strategy & risk management with major global fast moving consumer good companies.


She is the  Head of Basel Section and Board member of the Swiss Hospital Service of the Order of Malta, 


Suffering herself from rheumatoid arthritis in her youth, Anna gives a unique perspe

Finance and Operations


Anna has significant experience in controlling, strategy & risk management with major global fast moving consumer good companies.


She is the  Head of Basel Section and Board member of the Swiss Hospital Service of the Order of Malta, 


Suffering herself from rheumatoid arthritis in her youth, Anna gives a unique perspective as a patient who embraces digitalization of healthcare as a chance to improve patient outcomes and lives. 


Anna holds an M.Sc. (cum laude) International Management/CEMS from Rotterdam School of Management and executive education at IMD Lausanne and IESE Business School. 


Anna is an alumna of Evonik’s RISE talent program and a One Young World Ambassador

Albrecht Tribukait, PhD, MBA

Albrecht Tribukait, PhD, MBA

Albrecht Tribukait, PhD, MBA

Regulations and Compliance


Albrecht is a transformational leader with an international career of more than 20 years at the interface of science, policy and regulation in fast-paced Biotech and FMCG environments of significant growth


Extensive experience in national and supranational regulation of consumer products and non-food products
Albr

Regulations and Compliance


Albrecht is a transformational leader with an international career of more than 20 years at the interface of science, policy and regulation in fast-paced Biotech and FMCG environments of significant growth


Extensive experience in national and supranational regulation of consumer products and non-food products
Albrecht has conducted, directed, commissioned and published scientific and clinical research, and forged first-in-class partnerships with NGO and strategic collaboration with government-owned research organisations advancing evidence-informed approaches to public health policy and practice. 


Ph.D. in Natural Sciences from the University of Göttingen, MBA from Anaheim University Akio Morita School of Business, postgraduate certificates from Oxford and Hull.

Mark Edwards, JD

Albrecht Tribukait, PhD, MBA

Albrecht Tribukait, PhD, MBA

Legal and Intellectual Property


Mark has 27 years of global legal experience
Former Vice President and  General Counsel of Butamax®Advanced Biofuels LLC (Joint Venture between BP and DuPont)

He was General Counsel and Compliance Officer of Ilera Healthcare, a successful startup 

Corporate Intellectual Property Litigation Counsel for DuPon

Legal and Intellectual Property


Mark has 27 years of global legal experience
Former Vice President and  General Counsel of Butamax®Advanced Biofuels LLC (Joint Venture between BP and DuPont)

He was General Counsel and Compliance Officer of Ilera Healthcare, a successful startup 

Corporate Intellectual Property Litigation Counsel for DuPont strategic businesses - 13 years

Extensive technology, licensing and commercial transaction experience

Registered U.S. Patent Attorney - United States Patent and Trademark OfficeIntellectual Property consultant for startups and emerging companies
B.A. Chemistry - Kenyon College

Copyright © 2018-2022 OptiChroniX GmbH - All Rights Reserved.

Schönenbuch - Switzerland

  • Privacy Policy
  • Terms and Conditions

Cookie Policy

This website uses cookies. By continuing to use this site, you accept our use of cookies. Privacy Policy

DeclineAccept & Close